Evidence map›Paper›PMID 34576237›Full record

ArticleInternational journal of molecular sciences2021

Enhanced Antiviral Function of Magnesium Chloride-Modified Heparin on a Broad Spectrum of Viruses.

Kemal Mese, Oskar Bunz, Wolfram Volkwein, Sahithya P B Vemulapalli, Wenli Zhang, Sebastian Schellhorn, Kristin Heenemann, Antje Rueckner, Andreas Sing, Thomas W Vahlenkamp and 10 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Anti-HSV-1 agents: an update.Frontiers in pharmacology · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Metal Binding to Sodium Heparin Monitored by Quadrupolar NMR.International journal of molecular sciences · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kemal MeseVirology and Microbiology, Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University, 58453 Witten, Germany.
Oskar BunzVirology and Microbiology, Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University, 58453 Witten, Germany.ORCID 0000-0003-1483-8827
Wolfram VolkweinBavarian Health and Food Safety Authority (LGL), 85764 Oberschleissheim, Germany.
Sahithya P B VemulapalliDepartment of NMR-Based Structural Biology, Max Planck Institute for Biophysical Chemistry, 37077 Göttingen, Germany.ORCID 0000-0001-7773-7527
Wenli ZhangVirology and Microbiology, Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University, 58453 Witten, Germany.
Sebastian SchellhornVirology and Microbiology, Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University, 58453 Witten, Germany.ORCID 0000-0002-2786-7734
Kristin HeenemannCenter for Infectious Diseases, Institute of Virology, Faculty of Veterinary Medicine, University of Leipzig, 04103 Leipzig, Germany.ORCID 0000-0003-2330-5029
Antje RuecknerCenter for Infectious Diseases, Institute of Virology, Faculty of Veterinary Medicine, University of Leipzig, 04103 Leipzig, Germany.
Andreas SingBavarian Health and Food Safety Authority (LGL), 85764 Oberschleissheim, Germany.
Thomas W VahlenkampCenter for Infectious Diseases, Institute of Virology, Faculty of Veterinary Medicine, University of Leipzig, 04103 Leipzig, Germany.
Anna-Lena SeveringCentre for Biomedical Education and Research (ZBAF), Institute for Translational Wound Research, Witten/Herdecke University, 58453 Witten, Germany.ORCID 0000-0002-7344-5081
Jian GaoVirology and Microbiology, Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University, 58453 Witten, Germany.
Malik AydinCenter for Child and Adolescent Medicine, Center for Clinical and Translational Research (CCTR), Helios University Hospital Wuppertal, Witten/Herdecke University, 42283 Wuppertal, Germany.
Dominik JungCentre for Biomedical Education and Research, Institute of Pharmacology and Toxicology, Witten/Herdecke University, 58453 Witten, Germany.ORCID 0000-0003-4288-6455
Hagen S BachmannCentre for Biomedical Education and Research, Institute of Pharmacology and Toxicology, Witten/Herdecke University, 58453 Witten, Germany.
Kurt S ZänkerCenter for Biomedical Education and Research (ZBAF), Institute of Immunology, Witten/Herdecke University, 58453 Witten, Germany.
Ulrich BuschBavarian Health and Food Safety Authority (LGL), 85764 Oberschleissheim, Germany.
Armin BaikerVirology and Microbiology, Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University, 58453 Witten, Germany.
Christian GriesingerCentre for Biomedical Education and Research, Institute of Pharmacology and Toxicology, Witten/Herdecke University, 58453 Witten, Germany.
Anja EhrhardtVirology and Microbiology, Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University, 58453 Witten, Germany.

Funding

Deutsche Forschungsgemeinschaft EH 192/5-3
6 · The paper itself

Abstract

Previous studies reported on the broad-spectrum antiviral function of heparin. Here we investigated the antiviral function of magnesium-modified heparin and found that modified heparin displayed a significantly enhanced antiviral function against human adenovirus (HAdV) in immortalized and primary cells. Nuclear magnetic resonance analyses revealed a conformational change of heparin when complexed with magnesium. To broadly explore this discovery, we tested the antiviral function of modified heparin against herpes simplex virus type 1 (HSV-1) and found that the replication of HSV-1 was even further decreased compared to aciclovir. Moreover, we investigated the antiviral effect against the new severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and measured a 55-fold decreased viral load in the supernatant of infected cells associated with a 38-fold decrease in virus growth. The advantage of our modified heparin is an increased antiviral effect compared to regular heparin.

Indexed as

AcyclovirAdenoviruses, HumanAnimalsAntiviral AgentsCell Line, TumorChlorocebus aethiopsCHO CellsCricetulusDrug Evaluation, PreclinicalFibroblastsHeparinHerpesvirus 1, HumanHumansMagnesium ChlorideMagnetic Resonance SpectroscopyMicrobial Sensitivity TestsAcyclovirAntiviral AgentsHeparinMagnesium ChlorideadenovirusantiviralHSV-1magnesium chloridemodified heparinNMRSARS-CoV-2

Identifiers

PMID34576237
PMCPMC8466540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.